US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Holdings

3,102.20

+36.881.20%

Number of Gainers:52

Number of Losers:22

Number of Flat:1

PE:- -

High:3,115.98

Open:3,072.01

Low:3,072.01

Close:3,065.34

Loading ...

Darden Restaurants Expects More Olive Garden Momentum -- Market Talk

BofA expects no changes for Regenxbio regimen after competitor safety issue

Alibaba Stock (BABA) Falls on U.S.-China Worries

BRIEF-Deliveroo Shareholders Approve Doordash Scheme Implementation

Deliveroo Shareholders Approve Acquisition by DoorDash

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live

Deliveroo Plc - Shareholders Approve DoorDash Scheme Implementation

THOMSON REUTERS

Beam Therapeutics (BEAM) Gets a Buy from Wedbush

WeRide Signs MoU With Uber, Dubai's Transport Authority to Roll Out Pilot Phase of Autonomous Vehicles

MT Newswires Live

DoorDash Acquires SevenRooms in $1.2 Billion Deal

Psg Completes Sale of Minority Stake in Sevenrooms to DoorDash

THOMSON REUTERS

Alibaba Grants Employee Awards Under 2024 Plan

DoorDash and PC Optimum™ Reward Canadians With New Loyalty Integration

THOMSON REUTERS

Alibaba Health Announces Change in Hong Kong Share Registrar

Gossamer Bio Completes Enrollment in Phase 3 PROSERA Study for PAH Treatment, Topline Results Expected February 2026

Gossamer Bio Inc. Enters Global Collaboration Agreement with Chiesi Group for Development of Seralutinib

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 Prosera Study for the Treatment of Pah

THOMSON REUTERS

Gossamer Bio Inc - Topline Results From Phase 3 Prosera Study Expected February 2026

THOMSON REUTERS

ADC Therapeutics announces new data from Phase 2 trial of Zynlonta

Axsome Therapeutics supports Migraine, Headache Awareness Month

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4505/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4505","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","market":"US","secType":"PLATE","nameCN":"Hillhouse Capital Holdings","latestPrice":3102.216,"timestamp":1750099621371,"preClose":3065.3352,"halted":0,"volume":168141558,"delay":0,"changeRate":0.012032,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":36.880859,"latestTime":"06-16 14:47:02 EDT","open":3072.0056,"high":3115.9844,"low":3072.0056,"amount":13525454249.635534,"amplitude":0.014347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750104000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.124542,"peRate":26.560567,"turnoverRate":0.004174,"increases":52,"decrements":22,"flats":1,"marketCap":5729458872611,"floatMarketCap":5361411207336.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","high":3115.9844,"amplitude":0.014347,"preClose":3065.3352,"low":3072.0056,"pbRate":"8.124542","latestPrice":3102.195,"volume":168150989,"delay":0,"open":3072.0056,"prevYearClose":3417.1636,"prevWeekClose":3065.3352,"prevMonthClose":3046.7104,"prevQuarterClose":3159.8425,"fiveDayClose":3122.9636,"twentyDayClose":3179.716,"sixtyDayClose":3153.9392,"secType":"PLATE","market":"US","turnoverRate":0.004175,"peRate":26.560567,"marketCap":5729250332163,"floatMarketCap":5361202383336.5,"timestamp":1750099623904,"nameCN":"Hillhouse Capital Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4505\",,,,undefined,":{"bkCode":"BK4505","up":52,"down":22,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4505\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544022356","title":"Darden Restaurants Expects More Olive Garden Momentum -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2544022356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544022356?lang=en_us&edition=fundamental","pubTime":"2025-06-17 01:50","pubTimestamp":1750096200,"startTime":"0","endTime":"0","summary":"1350 ET - UBS expects Darden Restaurants to show a strong sales trajectory among key brands when it report F4Q results slated for Friday. Marketing efforts, new menu items and contributions from Uber Direct should result in solid trends across the restaurant operator's Olive Garden and LongHorn Steakhouse brands, analysts say in a research note. Still, investors' main focus will likely be Darden's fiscal 2026 guidance. UBS says expectations are that Olive Garden same store sales strengthened further into F1Q26, suggesting initial FY26 adjusted EPS guidance in a range of about $10.60-10.80 versus consensus of $10.73. Darden rises 3%. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4230","BK4536","LU1861214812.USD","LU1988902786.USD","IE00B7SZLL34.SGD","GB00BDT5M118.USD","DRI","LU2087625088.SGD","SGXZ51526630.SGD","LU2264538146.SGD","IE00B19Z3581.USD","SG9999015986.USD","LU0106261372.USD","SG9999014906.USD","BK4535","LU1814569148.SGD","SG9999014914.USD","LU0719512351.SGD","SG9999015952.SGD","SGXZ31699556.SGD","LU1861219969.SGD","SGXZ99366536.SGD","BK4503","IE00BZ199S13.USD","LU2360107325.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0082616367.USD","LU0154245673.USD","SG9999015945.SGD","LU0154245756.USD","BK4551","BK4504","LU1064131342.USD","SG9999017495.SGD","SG9999018865.SGD","SG9999014898.SGD","BK4550","BK4585","BK4022","BK4588","IE00BFMHRM44.USD","LU1983260115.SGD","SGXZ81514606.USD","LU0127658192.USD","LU0353189680.USD","LU0006306889.USD","SG9999014880.SGD"],"gpt_icon":1},{"id":"2544602865","title":"BofA expects no changes for Regenxbio regimen after competitor safety issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2544602865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544602865?lang=en_us&edition=fundamental","pubTime":"2025-06-17 00:55","pubTimestamp":1750092914,"startTime":"0","endTime":"0","summary":"After a second death was reported for a patient using Sarepta’s (SRPT) Elevidys, BofA says the firm expects that immune prophylaxis will be in the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-expects-no-changes-for-regenxbio-regimen-after-competitor-safety-issue-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-expects-no-changes-for-regenxbio-regimen-after-competitor-safety-issue-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B2B36J28.USD","RGNX","IE00BJJMRZ35.SGD","BK4505","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4585","IE0009355771.USD","BK4563","SRPT"],"gpt_icon":0},{"id":"2543601841","title":"Alibaba Stock (BABA) Falls on U.S.-China Worries","url":"https://stock-news.laohu8.com/highlight/detail?id=2543601841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543601841?lang=en_us&edition=fundamental","pubTime":"2025-06-16 23:39","pubTimestamp":1750088379,"startTime":"0","endTime":"0","summary":"U.S.-China trade talks have failed to calm investors.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/alibaba-stock-baba-falls-on-u-s-china-worries?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/alibaba-stock-baba-falls-on-u-s-china-worries?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1008478684.HKD","LU1046422090.SGD","LU0918141705.HKD","BK4554","BK4587","BK4220","BK4565","BK4534","BK4579","LU0797268264.HKD","LU0348814723.USD","IE00BFMHRM44.USD","LU0128525689.USD","LU0251143458.SGD","LU0821914370.USD","LU0310800965.SGD","BABA","BK4527","BK4548","BK4588","LU1242518857.USD","BK4122","IE00B0JY6N72.USD","LU0880133367.SGD","LU0072462343.USD","LU0067412154.USD","BK4614","LU1515016050.SGD","BK4581","LU0348816934.USD","LU1769817096.USD","BK4575","LU0979878070.USD","BK4535","LU1105468828.SGD","LU1282648689.USD","BK4538","ALBmain","LU1823568750.SGD","BK4585","LU1048596156.SGD","LU0918141887.USD","BK4505","BK4524","09988","BK4607","LU0047713382.USD","LU1048588211.SGD","LU0072913022.USD","BK4533"],"gpt_icon":0},{"id":"2543609773","title":"BRIEF-Deliveroo Shareholders Approve Doordash Scheme Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609773","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543609773?lang=en_us&edition=fundamental","pubTime":"2025-06-16 23:38","pubTimestamp":1750088315,"startTime":"0","endTime":"0","summary":"BRIEF-Deliveroo Shareholders Approve Doordash Scheme ImplementationJune 16 (Reuters) - Deliveroo PLC ROO.L:DELIVEROO PLC  - RESULT OF MEETINGDELIVEROO PLC - SHAREHOLDERS APPROVE DOORDASH  SCHEME IMPLE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUC1WBDJV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4536","BK4548","ROO.UK","BK4549","LU2065171311.SGD","BK5154","BK4535","BK4503","LU2065169927.USD","LU2065171402.SGD","BK5063","DASH","LU2065170008.USD","BK4122","BK4551","BK4588","BK4585","BK4209"],"gpt_icon":0},{"id":"2543091876","title":"Deliveroo Shareholders Approve Acquisition by DoorDash","url":"https://stock-news.laohu8.com/highlight/detail?id=2543091876","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543091876?lang=en_us&edition=fundamental","pubTime":"2025-06-16 23:07","pubTimestamp":1750086460,"startTime":"0","endTime":"0","summary":"Deliveroo plc Class A ( ($GB:ROO) ) has provided an announcement. Deliveroo plc has announced that its shareholders have approved a cash acquisitio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/deliveroo-shareholders-approve-acquisition-by-doordash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/deliveroo-shareholders-approve-acquisition-by-doordash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","BK4549","BK4536","BK4551","BK4588","DASH","BK4209","BK4548","BK4122","LU2065169927.USD","LU2065171311.SGD","BK4503","LU2065171402.SGD","BK4535","BK4585","BK4505"],"gpt_icon":0},{"id":"2543606777","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543606777?lang=en_us&edition=fundamental","pubTime":"2025-06-16 23:02","pubTimestamp":1750086162,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,497.18 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis  and DBV Technologies , which rose 5.2% and 4.7% respectively. They were followed by telecommunications operator Telefonica  and Spanish lender Banco Santander , which were up 4.2% and 3.7% respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biotech firm Evaxion , which fell 2.8% and 2.3% respectively. They were followed by biopharmaceutical company argenx  and semiconductor company Sequans Communications , which were down 2.1% and 1.8% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana  and Adaptimmune Therapeutics , which advanced 19% and 5.1% respectively. They were followed by cruise line operator Carnival  and telecommunications oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","SQNS","BP","LU1093756325.SGD","LU0889565916.HKD","BDRX","SAN","LU1829250122.USD","LU0320765992.SGD","LU1162221912.USD","LU0109394709.USD","BK4007","BK4585","BK4588","BK7104","DBVT","TEF","BK4117","BK4139","AKTX","BK7142","BK4142","BK4532","BK4107","BK4115","NCNA","BK4201","BK4599","CUK","LU0072461881.USD","SAN.AU","IE00BKVL7J92.USD","LU0162691827.USD","AFG","BK4141","LU1093756168.USD","LU0154236417.USD","AUTL","IE00BZ1G4Q59.USD","BK4207","EVAX","VOD","BK4521","BK4132","CLLS","ARGX","ADAP","BK4505","LU0320765646.SGD"],"gpt_icon":1},{"id":"2543606086","title":"Deliveroo Plc - Shareholders Approve DoorDash  Scheme Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543606086?lang=en_us&edition=fundamental","pubTime":"2025-06-16 23:02","pubTimestamp":1750086158,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUC1WBDJV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4503","BK4209","BK4585","ROO.UK","BK4551","DASH","BK5063","BK4536","BK4588","BK4122","LU2065169927.USD","BK4505","LU2065170008.USD","BK4549","LU2065171311.SGD","LU2065171402.SGD","BK5154","BK4548"],"gpt_icon":0},{"id":"2543606040","title":"Beam Therapeutics (BEAM) Gets a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2543606040","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543606040?lang=en_us&edition=fundamental","pubTime":"2025-06-16 22:55","pubTimestamp":1750085720,"startTime":"0","endTime":"0","summary":"Wedbush analyst David Nierengarten maintained a Buy rating on Beam Therapeutics (BEAM – Research Report) today and set a price target of $57.00. Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beam-therapeutics-beam-gets-a-buy-from-wedbush-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beam-therapeutics-beam-gets-a-buy-from-wedbush-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4611","BEAM","BK4585","BK4556","BK4505","BK4535"],"gpt_icon":0},{"id":"2543670723","title":"WeRide Signs MoU With Uber, Dubai's Transport Authority to Roll Out Pilot Phase of Autonomous Vehicles","url":"https://stock-news.laohu8.com/highlight/detail?id=2543670723","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543670723?lang=en_us&edition=fundamental","pubTime":"2025-06-16 21:19","pubTimestamp":1750079950,"startTime":"0","endTime":"0","summary":"WeRide  said Monday it signed a memorandum of understanding with Uber Technologies  and Dubai's Roads and Transport Authority to roll out pilot phases of autonomous vehicles later in 2025 through the Uber application in Dubai.Financial terms were not disclosed.In the first phase, the vehicles will operate with a safety driver with full autonomous services to be launched next year, the company said.The field preparations for the pilot phase are already underway, led by WeRide and Uber, the autonomous driving technology company said.WeRide's stock was up 4% in recent Monday premarket activity, while Uber shares were 1.3% higher.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4536","SG9999018857.SGD","LU1861214812.USD","LU1988902786.USD","IE00B7SZLL34.SGD","GB00BDT5M118.USD","LU2087625088.SGD","SGXZ51526630.SGD","LU2264538146.SGD","IE00B19Z3581.USD","SGXZ81514606.USD","SG9999015986.USD","LU0106261372.USD","SG9999014906.USD","BK4535","LU1814569148.SGD","SG9999014914.USD","LU0719512351.SGD","SG9999015952.SGD","LU1316542783.SGD","SGXZ31699556.SGD","LU1861219969.SGD","SGXZ99366536.SGD","LU0353189763.USD","BK4503","IE00BZ199S13.USD","LU2360107325.USD","BK4609","UBER","IE00B19Z3B42.SGD","LU0082616367.USD","BK4124","SG9999015945.SGD","BK4551","SG9999015978.USD","LU1064131342.USD","SG9999018865.SGD","WRD","SG9999014898.SGD","BK4550","BK4585","BK4588","IE00BFMHRM44.USD","LU1983260115.SGD","LU0642271901.SGD","LU0127658192.USD","LU0353189680.USD","LU0006306889.USD","SG9999014880.SGD"],"gpt_icon":1},{"id":"2543670348","title":"DoorDash Acquires SevenRooms in $1.2 Billion Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2543670348","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543670348?lang=en_us&edition=fundamental","pubTime":"2025-06-16 21:00","pubTimestamp":1750078837,"startTime":"0","endTime":"0","summary":"DoorDash Inc. has announced the completion of its $1.2 billion acquisition of SevenRooms, a software company based in New York City that specializes in hospitality technology. This transaction includes the purchase of PSG's minority stake in SevenRooms. Founded in 2011, SevenRooms provides tools for marketing, operations, and guest experience in the restaurant and hospitality industry, and has expanded from 2,000 to over 13,000 venue customers since PSG's investment in 2020. As a DoorDash company, SevenRooms aims to enhance its services and innovation in supporting restaurant and hospitality partners.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DoorDash Inc. published the original content used to generate this news brief via Busines","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL80BM2H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4585","BK4536","BK4503","BK4551","BK4505","BK4209","LU2065170008.USD","BK4548","BK4588","DASH","BK4122","BK4549","BK4535","LU2065171311.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2543670308","title":"Psg Completes Sale of Minority Stake in Sevenrooms to DoorDash","url":"https://stock-news.laohu8.com/highlight/detail?id=2543670308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543670308?lang=en_us&edition=fundamental","pubTime":"2025-06-16 21:00","pubTimestamp":1750078805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SJ09V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU2065171402.SGD","LU2065170008.USD","BK4549","BK4503","BK4548","BK4551","DASH","BK4505","BK4122","LU2065171311.SGD","LU2065169927.USD","BK4585","BK4209","BK4535","BK4536"],"gpt_icon":0},{"id":"2543672715","title":"Alibaba Grants Employee Awards Under 2024 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2543672715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543672715?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:13","pubTimestamp":1750076018,"startTime":"0","endTime":"0","summary":"Alibaba Group Holding Ltd. ( ($HK:9988) ) just unveiled an announcement. Alibaba Group Holding Ltd. announced the grant of awards involving 7,687,0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alibaba-grants-employee-awards-under-2024-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alibaba-grants-employee-awards-under-2024-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0918141887.USD","LU0328353924.USD","BK4504","LU0047713382.USD","LU1051768304.USD","BK4527","BK4122","BK4526","BK4581","LU0501845795.SGD","IE00BFMHRM44.USD","BK4535","LU0797268264.HKD","BK4220","IE00B0JY6N72.USD","LU0348814723.USD","LU1769817179.HKD","LU1152091168.USD","BK4588","LU1515016050.SGD","LU1242518857.USD","LU1048596156.SGD","BK4614","LU2226246903.HKD","BK4565","BK4543","09988","BK4607","LU0979878070.USD","LU1008478684.HKD","LU1242518931.SGD","LU0072913022.USD","LU0651946864.USD","LU1282648689.USD","LU1880383366.USD","BK4534","BK4538","ALBmain","LU0821914370.USD","BK4575","BABA","LU0052756011.USD","LU1105468828.SGD","BK4558","LU0651947912.USD","LU1048588211.SGD","LU0251143458.SGD","LU1267930227.SGD","BK4585","BK4505"],"gpt_icon":0},{"id":"2543747366","title":"DoorDash and PC Optimum™ Reward Canadians With New Loyalty Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2543747366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543747366?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:00","pubTimestamp":1750075206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUA3PKPFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","BK4535","BK4548","LU2065170008.USD","BK4588","LU2065171402.SGD","BK4503","BK4536","BK4551","LU2065169927.USD","BK4122","DASH","BK4585","BK4549","BK4209","BK4505"],"gpt_icon":0},{"id":"2543681674","title":"Alibaba Health Announces Change in Hong Kong Share Registrar","url":"https://stock-news.laohu8.com/highlight/detail?id=2543681674","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543681674?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:37","pubTimestamp":1750073850,"startTime":"0","endTime":"0","summary":"Alibaba Health Information Technology ( ($HK:0241) ) has shared an update. Alibaba Health Information Technology Limited has announced a change in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alibaba-health-announces-change-in-hong-kong-share-registrar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alibaba-health-announces-change-in-hong-kong-share-registrar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0651946864.USD","LU0918141705.HKD","LU0047713382.USD","BK4503","LU0918141887.USD","LU0797268264.HKD","LU1242518857.USD","LU1051768304.USD","BK4581","LU1046421795.USD","LU1048596156.SGD","LU1769817179.HKD","LU0251143458.SGD","LU0328353924.USD","BK4504","BK4565","LU1105468828.SGD","BK4524","BK4220","LU1880383366.USD","BK4588","LU1769817096.USD","LU1051769294.HKD","LU1152091168.USD","ALBmain","LU0821914370.USD","LU1048588211.SGD","BK4505","LU1515016050.SGD","BK4543","LU1235294995.USD","BK4558","BK4538","LU0052756011.USD","LU1823568750.SGD","LU1282648689.USD","LU0072913022.USD","LU0979878070.USD","BK4587","LU0072462343.USD","LU0348816934.USD","BK4548","BK4579","BK4502","LU0501845795.SGD","BK4122","LU1242518931.SGD","BK4535"],"gpt_icon":0},{"id":"2543671046","title":"Gossamer Bio Completes Enrollment in Phase 3 PROSERA Study for PAH Treatment, Topline Results Expected February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2543671046","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543671046?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:32","pubTimestamp":1750073521,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. , a late-stage clinical biopharmaceutical company, has announced the completion of enrollment for its global registrational Phase 3 PROSERA Study, which is evaluating the drug seralutinib for the treatment of pulmonary arterial hypertension . The Phase 3 study involves 390 participants and is designed as a double-blind, placebo-controlled trial. The primary endpoint focuses on the change in six-minute walk distance from baseline as compared to placebo at week 24, with key secondary endpoints including time to clinical worsening up to week 48. The study also assesses safety and tolerability. Topline results from the PROSERA Study are anticipated to be announced in February 2026. This follows insights gained from the earlier Phase 2 TORREY Study, with the current patient population closely aligning with the study's objectives.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDLVh6F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2543267104","title":"Gossamer Bio Inc. Enters Global Collaboration Agreement with Chiesi Group for Development of Seralutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2543267104","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543267104?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:31","pubTimestamp":1750073480,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc., a clinical biopharmaceutical company, has entered into a global collaboration agreement with the Chiesi Group to jointly develop seralutinib for the treatment of pulmonary arterial hypertension . This partnership aims to advance seralutinib as a potential first-in-class treatment option, with the companies focusing on Functional Class II and III PAH patients. The collaboration is currently centered on the ongoing Phase 3 PROSERA Study, which recently completed enrollment. This study is a critical step in evaluating the efficacy of seralutinib and is expected to yield topline results in February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL9GsDyF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2543671050","title":"Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 Prosera Study for the Treatment of Pah","url":"https://stock-news.laohu8.com/highlight/detail?id=2543671050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543671050?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:31","pubTimestamp":1750073460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUA4THQV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2543097671","title":"Gossamer Bio Inc - Topline Results From Phase 3 Prosera Study Expected February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2543097671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543097671?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:31","pubTimestamp":1750073460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nTUA4THQV7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2543472671","title":"ADC Therapeutics announces new data from Phase 2 trial of Zynlonta","url":"https://stock-news.laohu8.com/highlight/detail?id=2543472671","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543472671?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:20","pubTimestamp":1750072829,"startTime":"0","endTime":"0","summary":"ADC Therapeutics (ADCT) announced updated data from a Phase 2 multicenter investigator-initiated trial of Zynlonta to treat relapsed/refractory mar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-announces-new-data-from-phase-2-trial-of-zynlonta-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adc-therapeutics-announces-new-data-from-phase-2-trial-of-zynlonta-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","BK4505","BK4007","LENZ","ADCT","BK4080","BK4539","BK4139"],"gpt_icon":0},{"id":"2543404671","title":"Axsome Therapeutics supports Migraine, Headache Awareness Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2543404671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543404671?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:20","pubTimestamp":1750072814,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) recognizes Migraine and Headache Awareness Month alongside the Association of Migraine Disorders. In honor of this year’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-supports-migraine-headache-awareness-month-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-supports-migraine-headache-awareness-month-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","BK4585","BK4505","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":26,"pageCount":1,"totalSize":509,"code":"91000000","status":"200"}]}}